701 related articles for article (PubMed ID: 32508065)
1. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
3. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
4. KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results.
Griffin BR; You Z; Noureddine L; Gitomer B; Perrenoud L; Wang W; Chonchol M; Jalal D;
Am J Nephrol; 2020; 51(6):473-479. PubMed ID: 32541154
[TBL] [Abstract][Full Text] [Related]
5. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
[TBL] [Abstract][Full Text] [Related]
6. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
[TBL] [Abstract][Full Text] [Related]
7. Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.
Kim H; Park S; Jhee JH; Yun HR; Park JT; Han SH; Lee J; Kim SW; Kim YH; Oh YK; Kang SW; Choi KH; Yoo TH;
BMC Nephrol; 2019 Mar; 20(1):104. PubMed ID: 30909873
[TBL] [Abstract][Full Text] [Related]
8. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
[TBL] [Abstract][Full Text] [Related]
9. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
Xu Z; Xu B; Xu C
Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
[TBL] [Abstract][Full Text] [Related]
11. Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study.
Park HC; Hong Y; Yeon JH; Ryu H; Kim YC; Lee J; Kim YH; Chae DW; Chung W; Ahn C; Oh KH; Oh YK
Kidney Res Clin Pract; 2022 Jul; 41(4):432-441. PubMed ID: 35286789
[TBL] [Abstract][Full Text] [Related]
12. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
13. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
[TBL] [Abstract][Full Text] [Related]
15. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
Leierer J; Perco P; Hofer B; Eder S; Dzien A; Kerschbaum J; Rudnicki M; Mayer G
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206927
[TBL] [Abstract][Full Text] [Related]
16. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
17. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
[TBL] [Abstract][Full Text] [Related]
18. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
[TBL] [Abstract][Full Text] [Related]
19. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
